ABSTRACT
Objective: To compare patient and nurse satisfaction with intravenous patient-controlled analgesia (IV-PCA) to their prospective satisfaction with patient-controlled transdermal delivery system (PCTS) technology.
Methods: Nationwide samples of 301 nurses (200 medical-surgical, 101 post-anesthesia care units) and 500 surgery patients (192 abdominal, 119 gynecological, 189 orthopedic) completed self-administered, Internet-based questionnaires. Respondents indicated satisfaction with attributes of IV‐PCA and, after reading a description of PCTS, indicated prospective satisfaction with comparable attributes. Within patient and nurse samples, half rated IV-PCA first (and later re-rated overall satisfaction) and half rated PCTS first. Paired comparison t-tests were used to determine significant differences in satisfaction for IV‐PCA and PCTS attributes.
Results: Nurses reported significantly higher satisfaction with PCTS for patient and nurse ease of use, safety, and tolerability ( p < 0.001 for all); and higher satisfaction with IV‐PCA for the ability to vary drugs ( p < 0.001) and doses ( p < 0.001), deliver basal doses ( p < 0.001), and dose tracking accessibility ( p = 0.003) and quality ( p = 0.002). Patients reported significantly higher satisfaction with PCTS for pain relief ( p < 0.001), safety ( p = 0.027), self-control ( p < 0.001), and patient ( p < 0.001) and nurse ease of use ( p < 0.001); and higher satisfaction with IV‐PCA for correct set-up and programming ( p = 0.002). Overall satisfaction did not differ significantly among nurses, but among patients satisfaction with IV‐PCA declined after considering PCTS ( p < 0.001). Nurses placed greater importance on safety to their overall satisfaction than patients did.
Limitations: Only respondents with Internet access were included. PCTS satisfaction is hypothetical and may not reflect true product satisfaction.
Conclusion: PCTS is a novel delivery system for postoperative pain and has the potential to improve patient and nurse satisfaction over IV‐PCA.